Medical Writing Real-World Data, Real-World Evidence Defining the quality of data within rare disease registries: A systematic review
cover-343_page_1png

Volume 34, Issue 3 - Real-World Data, Real-World Evidence

Defining the quality of data within rare disease registries: A systematic review

Abstract

Rare diseases have a low prevalence within society, resulting in limited awareness and challenges with data availability for research. While rare disease registries offer valuable data, ensuring quality of the data is essential. This review explores key themes and influencing factors affecting data quality in rare disease registries. Studies were identified through a pre-defined search term across multiple databases and screened for recurring themes and terms. The findings indicate a growing emphasis on data quality and evolving perspectives on how it is defined and assessed through the years.

 

Medical Writing. 2025;34(3):34–39. https://doi.org/10.56012/knxk2392

Download the full article

Search

Articles

Real-world data and real-world evidence: A new ethics of knowing
President's Message
From the Editor
EMWA News
In Memory of Keith Veitch
Real-world evidence and real-world data in contemporary healthcare: A critical overview
Real-world data and evidence: A European regulatory perspective
From data to impact: Exploring the evolution of real-world evidence at the FDA
Expanding the safety horizon: How real-world evidence shapes drug safety
Defining the quality of data within rare disease registries: A systematic review
Lessons learnt from PETHEMA’s RWD research: A clinical perspective
Real-world data in clinical development: Statistical considerations and reporting challenges
Embracing the potential of real-world data: An industry perspective
The role of real-world evidence in post-market clinical follow-up
From algorithms to insights: The role of medical writers in AI-enhanced real-world evidence
Real-world evidence: What does the medical writer need to know?
Artificial intelligence and machine learning in real-world evidence: Transforming data into actionable insights
The paradigm of real-word evidence in lifestyle medicine: Insights, considerations, and opportunities for medical writers
Silenced data: How banning words undermines real-world evidence in medical writing
News from the EMA
Gained in Translation
Medical Communications and Writing for Patients
Regulatory Matters
Medical Devices
My First Medical Writing

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief

Raquel Billiones

Co-Editors

Evguenia Alechine

Jonathan Pitt

Senior Editor

Victoria White

Managing Editor

Alicia Brooks Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir

AI/Automation

Jennifer Bell

Biotechnology

Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Adriana Rocha

Freelancing

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Pablo Izquierdo / Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer

Publications

Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Tiziana von Bruchhausen

Pharmacovigilance

Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Jeff Blair / Luiza Ventura

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk